Karad Multi Speciality Hospital & Research Centre Profile
Key Indicators
- Authorised Capital ₹ 6.00 Cr
as on 19-12-2024
- Paid Up Capital ₹ 4.80 Cr
as on 19-12-2024
- Company Age 8 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -13.26%
(FY 2021)
- Profit 1683.40%
(FY 2021)
- Ebitda 60.16%
(FY 2021)
- Net Worth 13.95%
(FY 2021)
- Total Assets 14.98%
(FY 2021)
About Karad Multi Speciality Hospital & Research Centre
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 6.00 Cr and a paid-up capital of Rs 4.80 Cr, as per Ministry of Corporate Affairs (MCA) records.
Anil Desai, Abhijeet Patil, Vaibhavkumar Chavan, and Nine other members serve as directors at the Company.
- CIN/LLPIN
U85120PN2016PTC165520
- Company No.
165520
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Jul 2016
- Date of AGM
24 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Satara, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Karad Multi Speciality Hospital & Research Centre?
Board Members(12)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rehana Mulla  | Director | 20-Jan-2018 | Current |
| Anil Desai | Director | 15-Jul-2016 | Current |
| Abhijeet Patil | Director | 15-Jul-2016 | Current |
| Vaibhavkumar Chavan | Director | 15-Jul-2016 | Current |
| Chinmay Wingkar | Director | 15-Jul-2016 | Current |
| Sushil Savant | Director | 15-Jul-2016 | Current |
Financial Performance of Karad Multi Speciality Hospital & Research Centre.
Karad Multi Speciality Hospital & Research Centre Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 13.26% decrease. The company also saw a substantial improvement in profitability, with a 1683.4% increase in profit. The company's net worth Soared by an impressive increase of 13.95%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Karad Multi Speciality Hospital & Research Centre?
In 2021, Karad Multi Speciality Hospital & Research Centre had a promoter holding of 17.19% and a public holding of 82.81%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Karad Multi Speciality Hospital & Research Centre?
Karad Multi Speciality Hospital & Research Centre has a workforce of 50 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Karad Multi Speciality Hospital & Research Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Karad Multi Speciality Hospital & Research Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
